Containment, Hormones, In-Vitro and Pharmacy

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Containment

Hormones

In-Vitro

Pharmacy

Meeting public expectations of diagnostics is the next big test for the NHS

pharmaphorum

MARCH 11, 2021

The UK’s perceived failure to contain the initial spread of the virus was, we were told, in part due to a lesser focus on test and trace procedures than in some other countries, and that was down to us not having a tradition of diagnostics in this country. Over a year ago PCR testing was not a familiar term but is now known by general public.

In-Vitro

In-Vitro Containment Radiology Life Science

U.S. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™

Pfizer

DECEMBER 20, 2022

FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™. Tuesday, December 20, 2022 - 04:30pm. Pfizer oral treatment remains available to eligible U.S. patients under Emergency Use Authorization as a critical tool in the fight against COVID-19. NEW YORK, December 20, 2022 -- Pfizer Inc. NYSE: PFE) announced today that the U.S. In the U.S.,

Drugs

Drugs Licensing Licensing Containment

Clinical Research Informer

Meeting public expectations of diagnostics is the next big test for the NHS

U.S. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™

Stay Connected